SYRS
Geode Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-196,252
| Closed | -$45.1K | – | 4526 |
|
|
2024
Q4 | $45.1K | Sell |
196,252
-8,443
| -4% | -$1.94K | ﹤0.01% | 4259 |
|
|
2024
Q3 | $440K | Sell |
204,695
-21,415
| -9% | -$46.1K | ﹤0.01% | 3633 |
|
|
2024
Q2 | $1.17M | Buy |
226,110
+5,865
| +3% | +$30.3K | ﹤0.01% | 3249 |
|
|
2024
Q1 | $1.18M | Buy |
220,245
+58,682
| +36% | +$314K | ﹤0.01% | 3303 |
|
|
2023
Q4 | $1.26M | Buy |
161,563
+23,698
| +17% | +$185K | ﹤0.01% | 3258 |
|
|
2023
Q3 | $545K | Buy |
137,865
+8,002
| +6% | +$31.6K | ﹤0.01% | 3568 |
|
|
2023
Q2 | $409K | Buy |
129,863
+46,784
| +56% | +$147K | ﹤0.01% | 3726 |
|
|
2023
Q1 | $222K | Buy |
83,079
+12,563
| +18% | +$33.5K | ﹤0.01% | 3996 |
|
|
2022
Q4 | $253K | Buy |
70,516
+101
| +0.1% | +$362 | ﹤0.01% | 3967 |
|
|
2022
Q3 | $453K | Sell |
70,415
-413,296
| -85% | -$2.66M | ﹤0.01% | 3772 |
|
|
2022
Q2 | $465K | Sell |
483,711
-501,520
| -51% | -$482K | ﹤0.01% | 3809 |
|
|
2022
Q1 | $1.17M | Buy |
985,231
+32,031
| +3% | +$38.1K | ﹤0.01% | 3537 |
|
|
2021
Q4 | $3.11M | Buy |
953,200
+95,554
| +11% | +$311K | ﹤0.01% | 3146 |
|
|
2021
Q3 | $3.83M | Sell |
857,646
-108,802
| -11% | -$486K | ﹤0.01% | 3066 |
|
|
2021
Q2 | $5.27M | Buy |
966,448
+133,440
| +16% | +$727K | ﹤0.01% | 2865 |
|
|
2021
Q1 | $6.23M | Buy |
833,008
+242,906
| +41% | +$1.82M | ﹤0.01% | 2673 |
|
|
2020
Q4 | $6.4M | Buy |
590,102
+9,393
| +2% | +$102K | ﹤0.01% | 2466 |
|
|
2020
Q3 | $5.13M | Buy |
580,709
+16,908
| +3% | +$149K | ﹤0.01% | 2383 |
|
|
2020
Q2 | $6.01M | Buy |
563,801
+65,614
| +13% | +$699K | ﹤0.01% | 2223 |
|
|
2020
Q1 | $2.95M | Buy |
498,187
+22,641
| +5% | +$134K | ﹤0.01% | 2451 |
|
|
2019
Q4 | $3.29M | Buy |
475,546
+24,121
| +5% | +$167K | ﹤0.01% | 2710 |
|
|
2019
Q3 | $4.69M | Buy |
451,425
+5,503
| +1% | +$57.1K | ﹤0.01% | 2418 |
|
|
2019
Q2 | $4.13M | Buy |
445,922
+155,391
| +53% | +$1.44M | ﹤0.01% | 2513 |
|
|
2019
Q1 | $2.66M | Buy |
290,531
+40,863
| +16% | +$373K | ﹤0.01% | 2687 |
|
|
2018
Q4 | $1.39M | Buy |
249,668
+23,234
| +10% | +$129K | ﹤0.01% | 2961 |
|
|
2018
Q3 | $2.7M | Buy |
226,434
+11,490
| +5% | +$137K | ﹤0.01% | 2723 |
|
|
2018
Q2 | $2.19M | Buy |
214,944
+51,377
| +31% | +$524K | ﹤0.01% | 2802 |
|
|
2018
Q1 | $2.12M | Buy |
163,567
+67,812
| +71% | +$880K | ﹤0.01% | 2724 |
|
|
2017
Q4 | $931K | Buy |
95,755
+864
| +0.9% | +$8.4K | ﹤0.01% | 3131 |
|
|
2017
Q3 | $1.4M | Buy |
94,891
+11,070
| +13% | +$163K | ﹤0.01% | 2962 |
|
|
2017
Q2 | $1.35M | Buy |
83,821
+43,763
| +109% | +$704K | ﹤0.01% | 2955 |
|
|
2017
Q1 | $638K | Buy |
40,058
+4,222
| +12% | +$67.2K | ﹤0.01% | 3217 |
|
|
2016
Q4 | $435K | Buy |
35,836
+1,086
| +3% | +$13.2K | ﹤0.01% | 3315 |
|
|
2016
Q3 | $481K | Buy |
+34,750
| New | +$481K | ﹤0.01% | 3264 |
|